Ambrish Mithal
About
In The Last Decade
Ambrish Mithal
52 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Pathology and Forensic Medicine 902
- Endocrinology, Diabetes and Metabolism 900
- Surgery 496
- Nutrition and Dietetics 437
- Orthopedics and Sports Medicine 433
Countries citing papers authored by Ambrish Mithal
This map shows the geographic impact of Ambrish Mithal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ambrish Mithal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ambrish Mithal more than expected).
Fields of papers citing papers by Ambrish Mithal
This network shows the impact of papers produced by Ambrish Mithal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ambrish Mithal. The network helps show where Ambrish Mithal may publish in the future.
Co-authorship network of co-authors of Ambrish Mithal
This figure shows the co-authorship network connecting the top 25 collaborators of Ambrish Mithal. A scholar is included among the top collaborators of Ambrish Mithal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ambrish Mithal. Ambrish Mithal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy | 4 |
| 5 | 3 | |
| 6 | Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India. | 21 |
| 7 | 5 | |
| 8 | 26 | |
| 9 | 62 | |
| 10 | 7 | |
| 11 | 13 | |
| 12 | 33 | |
| 13 | 7 | |
| 14 | 21 | |
| 15 | 9 | |
| 16 | 6 | |
| 17 | 61 | |
| 18 | 16 | |
| 19 | 31 | |
| 20 | IOF position statement: vitamin D recommendations for older adults breakdown → | 560 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.